Alka Chaubey, Ph.D., FACMG
2022
In 2022, Alka Chaubey, Ph.D., FACMG earned a total compensation of $1.3M as Chief Medical Officer at Bionano Genomics.
Compensation breakdown
| Non-Equity Incentive Plan | $146,880 |
|---|---|
| Option Awards | $759,000 |
| Salary | $399,269 |
| Other | $12,680 |
| Total | $1,317,829 |
FACMG received $759K in option awards, accounting for 58% of the total pay in 2022.
FACMG also received $146.9K in non-equity incentive plan, $399.3K in salary and $12.7K in other compensation.
Rankings
In 2022, Alka Chaubey, Ph.D., FACMG's compensation ranked 2,493rd out of 5,742 executives tracked by ExecPay. In other words, FACMG earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,493 out of 5,742 | 57th |
Division Manufacturing | 1,372 out of 3,128 | 56th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 164 out of 485 | 66th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 50 out of 108 | 54th |
Industry Laboratory Analytical Instruments | 30 out of 46 | 35th |
Source: SEC filing on April 26, 2024.
FACMG's colleagues
We found two more compensation records of executives who worked with Alka Chaubey, Ph.D., FACMG at Bionano Genomics in 2022.